HAVANT, England, March 10 /PRNewswire-FirstCall/ -- Xyratex Ltd. (NASDAQ:XRTX), a leading provider of enterprise class data storage subsystems and storage process technology, will release its financial results for the fiscal first quarter ended February 29, 2008 after the market closes on Thursday, March 27, 2008. Conference Call Information The company will host a conference call to discuss its results at 2:00 p.m. PT/5:00 p.m. ET on Thursday, March 27, 2008. The conference call can be accessed online via the company's website http://www.xyratex.com/investors, or by telephone as follows: United States (888) 679-8018 Outside the United States (617) 213-4845 Passcode 72136533 A replay will be available via the company's website http://www.xyratex.com/investors, or can be accessed by telephone through April 3, 2008 as follows: United States (888) 286-8010 Outside the United States (617) 801-6888 Passcode 42753368 About Xyratex Xyratex is a leading provider of enterprise data storage subsystems and storage process technology. The company designs and manufactures enabling technology that provides OEM and disk drive manufacturer customers with data storage products to support high-performance storage and data communication networks. Xyratex has over 20 years of experience in research and development relating to disk drives, storage systems and high-speed communication protocols. Founded in 1994 in an MBO from IBM, and with headquarters in the UK, Xyratex has an established global base with R&D and operational facilities in Europe, the United States and Southeast Asia. For more information, visit Xyratex's web site at http://www.xyratex.com/. DATASOURCE: Xyratex Ltd. CONTACT: investors, Brad Driver, +1-408-325-7260, , or Marketing, Lisa Hart, +1-303-442-3449, , both of Xyratex Ltd. Web site: http://www.xyratex.com/

Copyright

XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more XORTX Therapeutics Charts.
XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more XORTX Therapeutics Charts.